Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.

Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, Hughes G, Salamanchuk Z, Calasanz MJ, Lahortiga I, Pocock CF, Dang R, Fidler C, Wainscoat JS, Boultwood J, Cross NC.

Br J Haematol. 2003 Jan;120(2):251-6.

PMID:
12542482
2.
3.

Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders.

Pardanani A, Tefferi A.

Blood. 2004 Oct 1;104(7):1931-9. Epub 2004 May 27. Review.

4.

Translocation t(5;12)(q31-q33;p12-p13): a non-random translocation associated with a myeloid disorder with eosinophilia.

Baranger L, Szapiro N, Gardais J, Hillion J, Derre J, Francois S, Blanchet O, Boasson M, Berger R.

Br J Haematol. 1994 Oct;88(2):343-7. Review.

PMID:
7803280
5.

Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.

Mozziconacci MJ, Carbuccia N, Prebet T, Charbonnier A, Murati A, Vey N, Chaffanet M, Birnbaum D.

Leuk Res. 2008 Aug;32(8):1304-8. Epub 2007 Dec 21. Review.

PMID:
18096225
6.

Tyrosine kinase fusion genes in chronic myeloproliferative diseases.

Cross NC, Reiter A.

Leukemia. 2002 Jul;16(7):1207-12. Review.

7.

Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders.

Cross NC, Reiter A.

Acta Haematol. 2008;119(4):199-206. doi: 10.1159/000140631. Epub 2008 Jun 20. Review.

PMID:
18566537
8.

Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.

Savage N, George TI, Gotlib J.

Int J Lab Hematol. 2013 Oct;35(5):491-500. doi: 10.1111/ijlh.12057. Epub 2013 Mar 13. Review.

PMID:
23489324
9.

Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.

Hu S, He Y, Zhu X, Li J, He H.

Pediatr Hematol Oncol. 2011 Mar;28(2):140-6. doi: 10.3109/08880018.2010.528170. Epub 2011 Jan 8. Review.

PMID:
21214407
10.

Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders.

Reiter A, Walz C, Cross NC.

Curr Drug Targets. 2007 Feb;8(2):205-16. Review.

PMID:
17305499
11.

Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes.

Adeyinka A, Dewald GW.

Hematol Oncol Clin North Am. 2003 Oct;17(5):1129-49. Review.

PMID:
14560778
12.

Identification of parental chromosomes involved in translocations BCR-ABL, t(9;22) and PML-RARA, t(15;17).

Chaudhuri JP, Karamanov S, Paulraj P, McGill JR, Walther J.

Anticancer Res. 2008 Nov-Dec;28(6A):3573-8. Review.

13.

Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.

Panani AD.

Cancer Lett. 2007 Sep 18;255(1):12-25. Epub 2007 Mar 23. Review.

PMID:
17383090
14.

t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia.

Wessels JW, Fibbe WE, van der Keur D, Landegent JE, van der Plas DC, den Ottolander GJ, Roozendaal KJ, Beverstock GC.

Cancer Genet Cytogenet. 1993 Jan;65(1):7-11. Review.

PMID:
8431918
15.

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

Macdonald D, Reiter A, Cross NC.

Acta Haematol. 2002;107(2):101-7. Review.

PMID:
11919391
16.

Molecular markers guide diagnosis and treatment in Philadelphia chromosome-negative myeloproliferative disorders (Review).

Vladareanu AM, Müller-Tidow C, Bumbea H, Radesi S.

Oncol Rep. 2010 Mar;23(3):595-604. Review.

PMID:
20126996
17.

Childhood myeloproliferative disorders.

Cotter FE.

Baillieres Clin Haematol. 1998 Dec;11(4):875-98. Review.

PMID:
10640222
18.

Molecular genetics and cytogenetics of myeloproliferative disorders.

Bench AJ, Nacheva EP, Champion KM, Green AR.

Baillieres Clin Haematol. 1998 Dec;11(4):819-48. Review.

PMID:
10640219
19.

8p11 myeloproliferative syndrome: a review.

Jackson CC, Medeiros LJ, Miranda RN.

Hum Pathol. 2010 Apr;41(4):461-76. doi: 10.1016/j.humpath.2009.11.003. Review.

PMID:
20226962
20.

Reciprocal translocation involving 3q21 in an unusual myeloproliferative disorder with myelodysplastic features and prominent dysmegakaryopoiesis.

Cedrone M, Mecucci C, Burgio VL, Diverio D, Petti MC, Alimena G.

Cancer Genet Cytogenet. 1991 Jan;51(1):73-8. Review.

PMID:
1984850
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk